
In recent years, zzso agents have been used clinically to treat various zzso zzso In May 2009, zzso zzso was approved in Japan for zzso zzso zzso zzso and was the first zzso agent for use in zzso To date, zzso is the only zzso agent whose survival benefit has been demonstrated in two global phase III zzso controlled trials, and has now been approved zzso Phase III clinical trials of other zzso agents comparing them with zzso as zzso treatment agents are now zzso Those agents target the vascular zzso growth factor, zzso growth factor zzso as well as target the zzso growth factor zzso zzso growth factor zzso and zzso target of zzso in addition to other molecules targeting other components of the signal zzso zzso This review outlines the main pathways involved in the development and progression of zzso and the agents that target these zzso Finally, current status and future perspective will also be zzso 

